The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety, tolerability, pharmacokinetics
and pharmacodynamics of SHR7280 tablets in premenopausal subjects with endometriosis. In
addition, this study will provide information on efficacy of SHR7280 tablets in premenopausal
subjects with endometriosis.